AMENDMENT #2 TO WARRANT AGREEMENT OUTLOOK THERAPEUTICS, INC. AND AMERICAN STOCK TRANSFER & TRUST COMPANY, LLC, AS WARRANT AGENTWarrant Agreement • December 23rd, 2019 • Outlook Therapeutics, Inc. • Biological products, (no disgnostic substances)
THIS AMENDMENT #2, dated effective as of December 23, 2019 (“Amendment #2”), to the Warrant Agreement, dated as of April 12, 2019, as amended June 11, 2019 (the “Warrant Agreement”), by and between Outlook Therapeutics, Inc., a Delaware corporation (the “Company”), and American Stock Transfer & Trust Company, LLC, a New York limited liability trust company, as Warrant Agent (the “Warrant Agent”). Capitalized terms used but not defined in this Amendment #2 shall have the meaning ascribed to them in the Warrant Agreement.
